DL-Glutamic Acid Monohydrate

Catalog No. :
ACPZLD374
CAS No. :
19285-83-7
Molecular Formula :
C5H11NO5
Molecular Weight :
165.15

IUPAC Name:glutamic acid hydrate

DL-Glutamic Acid Monohydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$61.00Login to see priceIn stockInquiry
1000g98%$120.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDL-Glutamic Acid Monohydrate
IUPAC Nameglutamic acid hydrate
MDL No.MFCD00150703
Molecular FormulaC5H11NO5
Molecular Weight165.15
SMILESNC(CCC(O)=O)C(O)=O.[H]O[H]
InChI KeyOZDAOHVKBFBBMZ-UHFFFAOYSA-N
SynonymSCHEMBL910049 | OZDAOHVKBFBBMZ-UHFFFAOYSA-N | AKOS022174795 | MFCD00150703 | AMY16018 | 2-azanylpentanedioic acid hydrate | HMS1571C03 | DTXCID1029095 | DL-GlutamicAcidMonohydrate | NCGC00260356-01 | FT-0625463 | 2-aminopentanedioic acid;hydrate | (+/-)-2
CAS No.19285-83-7
PubChem CID16219385

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACPZLD374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. ACPGNO703 route compound structure diagram
    ACPGNO70312738-64-6 In Stock
  6. Then
  7. ACPZLD374 route product structure diagram
    ACPZLD37419285-83-7 In Stock
Inquiry

2. ACPZLD374 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. ACAYHI683 route compound structure diagram
    ACAYHI683997-43-3 In Stock
  4. Then
  5. ACPZLD374 route product structure diagram
    ACPZLD37419285-83-7 In Stock
Inquiry

Comments (0)